
Worried about AI at work? Avoid these 5 leadership mistakes with your team
How managers address these concerns can make or break team morale and productivity. Experts say clear, honest communication is critical, but the wrong message can backfire, fueling fear instead of trust. Whether you're rolling out new tools or just starting the conversation, it's important to engage your team with transparency, context and empathy.
Below, two human resources experts break down five common mistakes to avoid when discussing AI with your team and provide guidance on navigating the discussion more effectively.
1. Acting like it's no big deal
According to the World Economic Forum, when managers dismiss or avoid discussing AI concerns, they often create bigger problems down the road.
'Business leaders can't bury their heads in the sand and hope for the best,' says Eric Mochnacz, director of operations at Red Clover HR in New Jersey. 'They must have up-front discussions about the benefits of AI in their business, the drawbacks, the potential impacts and the areas where they'll not allow AI usage.'
Chad V. Sorenson, president of Florida-based Adaptive HR Solutions, agrees that direct communication is key. 'Employees may feel AI threatens their jobs and may question leaders' motives for introducing AI tools,' he explains. So, 'address the fear and explore how AI can augment workflows and streamline repetitive tasks rather than replace workers.'
Takeaway: Don't downplay concerns about AI. Acknowledge employee fears openly and explain how AI will support, not replace, their work.
2. Throwing around 'AI' without defining it
AI isn't just one thing. Mochnacz explains that there's a significant difference between using generative AI to enhance email communications and utilizing AI chatbots to manage all customer interactions. Without these distinctions, employees don't understand what to expect from their workplace changes or how they can remain relevant.
'AI is such a buzzword, and leaders haven't taken the time to define it and understand the differences,' says Mochnacz. 'I've been in meetings where people ask, 'Can you do this with AI?' or 'Everyone's talking about AI, so we have to do something with it.''
He emphasizes the importance of clarifying the fundamentals:
Takeaway: Don't use 'AI' as a vague catchall. Clearly define what types of AI you're using, what they do and why they matter to your team.
3. Failing to explain the why
'Any time leaders announce a new program or procedure without employee buy-in, there could be fear, skepticism or anger,' Sorenson cautions.
Instead of simply telling employees what's changing, explain why the company needs AI. How does it fit into broader business goals? This context helps employees understand their role in the transition rather than viewing it as a threat.
'Ongoing two-way feedback is critical for continued refinement of how teams use AI to improve workflows, processes and results,' notes Sorenson.
Takeaway: Don't skip the context. Explain why AI is being adopted and how it supports your team's goals to build trust and buy-in.
4. Overhyping what AI can do
'Leaders promising that AI will handle everything don't have a clear understanding of its possibilities and limitations,' Sorenson says. For instance, AI can help employees understand benefit plans. But it can't handle nuanced harassment complaints or mental health concerns. 'AI systems must be trained to understand when a human must intervene,' he adds.
Mochnacz says the problem gets worse when leaders promise capabilities that may never materialize. 'We have no idea what AI is going to be able to do in a month, three months or a year,' he emphasizes. So, it's better to focus on specific, tested use cases rather than grand predictions about AI replacing everything.
Takeaway: Avoid making big promises. Focus on what AI can realistically do today, not speculative future capabilities.
5. Leaving people out of the process
'Whenever there's a business, industry or technology shift, involve those it may impact,' stresses Mochnacz. 'Have up-front, direct conversations with your people about their roles and how they see AI helping them be more effective.'
A recent MIT Sloan working paper finds that the most successful generative AI deployments consistently involve frontline workers from the earliest stages through rollout. Drawing on over 50 in-depth interviews, MIT researchers demonstrate that when employees help define the problem, co-design workflows, experiment with tools, and shape fair transition policies, not only does adoption improve, but worker productivity and job quality also rise.
The key here is framing AI as a collaboration partner rather than a threat. Mochnacz explains that when leaders present AI as a good reality for everyone, employees will engage with the technology. But when the message becomes "prove AI can't replace you," workers resist because it feels like an ultimatum.
Takeaway: Don't make AI decisions in a vacuum. Engage employees early and frame AI as a tool to support their work, rather than compete with it.
What successful AI communication looks like
Sorenson says poor AI communication shows up in obvious ways. You might notice more pushback in meetings, higher employee turnover or a spike in anxious watercooler conversations. These signals suggest that employees feel excluded or uncertain and may be bracing for the worst.
In contrast, when communication is clear and inclusive, team engagement improves. 'If your AI communication strategy is successful, employees should engage in the conversation,' Sorenson notes. 'They'll make suggestions to continue to refine its use, and demonstrate an increased productivity level.'
Look for those signs of healthy adoption: employees asking questions, suggesting improvements and using AI to work more efficiently. When teams feel empowered, not threatened, you know you've struck the right balance.
What is USA TODAY Top Workplaces 2025?
Do you work for a great company? Each year, USA TODAY Top Workplaces, a collaboration between Energage and USA TODAY, ranks organizations across the U.S. that excel at creating a positive work environment for their employees. Employee feedback determines the winners.
In 2025, over 1,500 companies earned recognition as top workplaces. Check out our overall U.S. rankings. You can also gain insights into top-ranked employers by checking out the links below.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Scientific Industries Completes Strategic Refocus and Secures Proceeds of $10 million to Accelerate Growth of Two Data-Driven Business Platforms; Divests Genie® Division to OHAUS Corporation's affiliate Troemner, LLC
BOHEMIA, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Scientific Industries Inc. (OTCQB: SCND) (the 'Company') announced that it has sold its Genie Division to Troemner, LLC, a manufacturing sister company of OHAUS Corporation, (the 'Buyer') for $9.6 million in cash less working capital adjustments, plus up to $1.5 million in cash earnout over a twelve-month period. The Company also entered into a transition services agreement and supply agreement under which it has agreed to supply product to the Buyer and provide transition services of the acquired business for up to a year. Strategic Refocus on High-Growth, AI-Driven Platforms 'For more than 70 years, Scientific Industries was known as the world leader in vortexing technologies and as the pioneer and inventor of the vortex mixer,' said Helena Santos, CEO of Scientific Industries. 'Today, we are transforming into a deep-tech, AI-enabling company focused on two of the pharmacy and pharmaceutical industries' largest opportunities: pharmacy automation and biomanufacturing. With SaaS-enabled, data-driven IP models and integrated hardware/software platforms, we are building long-term value for our shareholders and measurable impact for our customers.' Transforming Pharmacy Automation with VIVID Scientific Industries' Torbal division has rapidly evolved from analog pharmacy scales to become a leader in cloud-based pharmacy automation. The company launched its first VIVID automated pill counter in 2020 in response to the nationwide shortage of pharmacists, often referred to as 'Pharmageddon.' Since then, the platform has expanded to three devices, including the VIVID Workstation — a premier cloud-connected automated pill counting solution. To date, nearly 2,000 VIVID units have been deployed, supporting the monthly dispensing of millions of prescriptions. Scientific Industries is now developing the pharmacy industry's first machine learning ('ML') pill library, expected to launch in Q1 2026. This will allow the platform to continuously improve in accuracy and efficiency, create a robust data library and unlock new opportunities across the pharmacy value chain — from manufacturers and dispensers to law enforcement. 'Our vision is to become the 'digital leader of retail pharmacy' by providing critical infrastructure and intelligence to an underserved market of 24,000+ independent pharmacies in North America,' added Ms. Santos. Unlocking AI-Enabled Biomanufacturing with Scientific Bioprocessing The Company's second core platform, Scientific Bioprocessing, is pioneering the digitization of analog bioproduction with its real-time DOTS™ platform. By converting complex biological signals into machine-readable data, the platform lays the foundation for predictive, automated, and scalable biomanufacturing. 'AI has made strides across life sciences, but biomanufacturing lags behind — not due to lack of algorithms, but due to lack of usable data,' explained John Moore, Chairman of Scientific Industries. 'Our DOTS platform fills this gap, enabling automated, parallelized, and cost-effective data generation for smarter biologics, cell therapies, and bio-based production.' Capital Reallocation to Accelerate Platform Growth On April 18, 2025, Scientific Industries secured $1.5 million in financing from existing investors through the sale of its common stock and warrants to purchase up to $1.5 million in shares, with such warrants now having an expiration date of August 22, 2025 as a result of today's transaction. Proceeds from the sale of the Genie division and any warrant exercises will be reinvested directly into scaling the Torbal Division and Scientific Bioprocessing platforms. With over $27 million raised since 2020 plus the funds from this divestiture, the company is well-capitalized to drive growth across synthetic biology, pharmacy automation, and laboratory digitization markets. 'By exiting our legacy analog business and focusing on digital infrastructure, we're positioning Scientific Industries as a foundational technology provider for the next generation of intelligent life science operations,' said Mr. Moore. 'The future belongs to those who can measure, learn, and act in real-time.' BroadOak Capital Partners acted as financial advisor to the company on the divestiture. About Scientific Industries Scientific Industries (OTCQB: SCND), is a life science tool provider. It manufactures laboratory equipment, pill counters, and bioprocessing systems under the product name DOTS. Scientific Industries' products are generally used for research purposes in laboratories of universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies. To learn more, visit About OHAUS Corporation Headquartered in Parsippany, NJ, OHAUS Corporation manufactures an extensive line of high-precision electronic and mechanical balances, laboratory equipment, centrifuges and analytical instruments. OHAUS is a global leader in laboratory, industrial, and education markets as well as a host of specialty markets, including food preparation, pharmacy and jewelry. The Genie portfolio of products will join the OHAUS brand and portfolio of Laboratory Equipment, Centrifuges and Balances Forward Looking Statements 'Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-K.' Company Contact: Helena R. SantosCEO and PresidentPhone: 631-567-4700hsantos@ or: Joe DorameLytham Partners, LLCPhone: (602)889-9700SCND@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
EXCLUSIVE: AdTech-Focused Inuvo Reports Smaller Loss As Sales Jump 25%
Inuvo Inc. (NYSE:INUV) reported Thursday a second-quarter loss of 10 cents, compared to 12 cents a year ago, which is in line with the consensus estimates. Net loss for the quarter was $1.5 million compared to a net loss of $1.7 million. The artificial intelligence AdTech solutions provider reported sales of $22.67 million, which was below the consensus estimate of $23.73 million. Revenues jumped 25% year over year. Revenue from the company's two largest Platform clients and two largest Agencies & Brands clients grew more earnings on INUV Cost of revenue was $5.6 million, up from $2.9 million in the second quarter of 2024, related to higher Platform revenue. Gross profit increased 12% to $17.1 million, representing a gross margin of 75.4%, compared to $15.3 million and a gross margin of 84.0% a year ago. The lower gross margin year-over-year was primarily due to a change in product mix. Operating expenses were $19.1 million compared to $17.0 million. Adjusted EBITDA improved to a loss of $0.6 million from a loss of $0.7 million in the year-ago period. Price Action: INUV stock closed 0.76% lower at $5.25 on Thursday. Read Next:Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article EXCLUSIVE: AdTech-Focused Inuvo Reports Smaller Loss As Sales Jump 25% originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.


CNBC
25 minutes ago
- CNBC
Santoli's Thursday market wrap-up: Swift downside reversal in big indexes shows twitchy, erratic market running out of buyers
(These are the market notes on today's action by Mike Santoli, CNBC's Senior Markets Commentator. See today's video update from Mike above.) A swift downside reversal in the big indexes shows a twitchy, erratic market running out of eager buyers near the upper end of the past week's range. The opening rally attempt got its push from overnight overseas strength after strong China exports, positive European shipping trends and hope that the imposition of U.S. tariffs left room for negotiated exemptions. Twitchy bond-market action after some headlines on Fed governor Waller potentially having a better shot as President Trump's Fed Chair pick and after a soft 30-year Treasury auction had yields a bit higher across the board. Trump subsequently said he'd nominate Council of Economic Advisors chair Stephen Miran to what's left of the unexpired term. Isolated pockets of pronounced weakness in some earnings reporters and subsectors of tech. Eli Lilly 's disappointing weight-loss-drug results knocked the stock down 14%, and perhaps destabilized other crowded, large-cap growth names such as Visa (off 2.3%). Software stocks were bloodied, with a clanging guidance miss by cybersecurity player Fortinet triggering a flight from a group already seen as vulnerable in a more AI-centric world. Given all these hazards, the broader market hung together OK. The S & P has spent all week inside the range set by last Thursday's record high a bit above 6400 and Friday's post-payroll-report low just above 6200. Benign churn to alleviate overbought conditions or the start of a less trustworthy tape given loss of momentum, challenging seasonal factors and waning momentum? Damage to the S & P limited by Apple 's upside follow-through, the stock ahead by another 3% after it was seen as sidestepping further tariffs on its imports from India. The move only modestly closed its yawning 22-percentage-point underperformance relative to the Nasdaq-100 this year, but provided good ballast for the S & P 500. Weekly jobless claims a non-event, stuck in a benign range, though another uptick in continuing unemployment claims to a new cycle high, just under 2 million, accentuates the current low-metabolism labor market: weak hiring pace, few layoffs and muted labor supply (given retirements and immigration crackdowns). CPI next Tuesday is the next key macro input as the debate over the growth-inflation-policy interplay remains tense.